RecruitingNot ApplicableNCT05643144

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

Enhancing Shared Decision-making to Prompt and Guide Individualized Care for People With Alzheimer's Disease and Diabetes


Sponsor

Indiana University

Enrollment

62 participants

Start Date

Jul 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to test CGM ASSIST. This is a digital tool that uses an interactive information display-an easy-to-read screen designed to help people with dementia (or memory loss) and diabetes, as well as their caregivers and doctors. Managing diabetes is often difficult for people with memory issues. This study uses a Continuous Glucose Monitor (CGM), which is a device that tracks blood sugar levels in real-time. CGM ASSIST adds a new way to see this data through interactive displays. These displays show clear information and medical guidelines to help patients and caregivers make sense of the glucose readings. The study aims to: * Increase Awareness: Help patients and caregivers recognize the dangers of low blood sugar (hypoglycemia) and how to treat it. * Improve Teamwork: Encourage "shared decision-making," where patients, caregivers, and doctors work together to make health choices. * Test Feasibility: See if it is easy and helpful for people with memory loss to use these interactive displays in their daily lives. * Understand Experiences: Learn how the thoughts and feelings of patients and families affect how they manage diabetes. By using these interactive displays, the researchers hope to make it easier for families to understand their health needs and communicate better with their medical team. Participants will: * Answer a survey about how they manage their diabetes * Learn how to use a Continuous Glucose Monitor and wear it for 14 days * Answer 3 brief telephone surveys during these 14 days * Complete a clinic visit with their doctor and answer a final survey on how this visit went using the CGM ASSIST report


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is developing tools to improve shared decision-making between doctors, patients with both dementia and diabetes, and their caregivers — helping all parties make better decisions together about diabetes management when cognitive decline makes this more complicated. **You may be eligible if...** - The patient has both a diagnosis of mild cognitive impairment or dementia AND diabetes - The patient is taking at least one diabetes medication - The patient has had a visit to a participating primary care clinic in the last 12 months - The patient has a caregiver who interacts with them almost daily and is 18 or older - Both the patient and caregiver speak English and live in the community - Both have access to the internet **You may NOT be eligible if...** - The patient has a terminal illness - The patient uses an automated insulin pump - The caregiver does not interact with the patient regularly Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous Glucose Monitoring

CGM education and glucose data collection for 14 days with a device. Interviews with dyads to assess experience and awareness of hypoglycemic events.


Locations(1)

Eskenazi Health

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05643144


Related Trials